US Stock MarketDetailed Quotes

GLSI Greenwich LifeSciences

Watchlist
  • 12.380
  • +0.080+0.65%
Close Feb 14 16:00 ET
  • 12.380
  • 0.0000.00%
Post 16:01 ET
162.73MMarket Cap-15.28P/E (TTM)

Greenwich LifeSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
9.03%2.73M
52.27%2.66M
13.21%2.54M
16.01%9.33M
-2.03%2.84M
5.03%2.5M
126.02%1.75M
12.66%2.24M
74.87%8.04M
21.77%2.89M
Selling and administrative expenses
26.76%437.01K
-4.00%353.53K
-17.06%342.69K
4.13%1.63M
15.23%503.05K
-47.73%344.76K
162.94%368.26K
25.82%413.18K
50.67%1.56M
39.35%436.58K
-General and administrative expense
26.76%437.01K
-4.00%353.53K
-17.06%342.69K
4.13%1.63M
15.23%503.05K
-47.73%344.76K
162.94%368.26K
25.82%413.18K
50.67%1.56M
39.35%436.58K
Research and development costs
6.20%2.29M
67.29%2.31M
20.06%2.19M
18.89%7.7M
-5.09%2.33M
25.22%2.16M
117.86%1.38M
10.06%1.83M
81.93%6.48M
19.10%2.46M
Operating profit
-9.03%-2.73M
-52.27%-2.66M
-13.21%-2.54M
-16.01%-9.33M
2.03%-2.84M
-5.03%-2.5M
-126.02%-1.75M
-12.66%-2.24M
-74.87%-8.04M
-21.77%-2.89M
Net non-operating interest income expense
-45.71%60.34K
-54.19%54.72K
-44.91%64.01K
102.80%436.06K
-14.28%89.29K
73.55%111.14K
338.62%119.45K
493.51%116.18K
685.68%215.02K
531.30%104.17K
Non-operating interest income
-45.71%60.34K
-54.19%54.72K
-44.91%64.01K
102.80%436.06K
-14.28%89.29K
73.55%111.14K
338.62%119.45K
493.51%116.18K
685.68%215.02K
531.30%104.17K
Other net income (expense)
Income before tax
-11.58%-2.67M
-60.08%-2.61M
-16.39%-2.47M
-13.63%-8.89M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-71.21%-7.83M
-18.21%-2.79M
Income tax
Net income
-11.58%-2.67M
-60.08%-2.61M
-16.39%-2.47M
-13.63%-8.89M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-71.21%-7.83M
-18.21%-2.79M
Net income continuous Operations
-11.58%-2.67M
-60.08%-2.61M
-16.39%-2.47M
-13.63%-8.89M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-71.21%-7.83M
-18.21%-2.79M
Minority interest income
Net income attributable to the parent company
-11.58%-2.67M
-60.08%-2.61M
-16.39%-2.47M
-13.63%-8.89M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-71.21%-7.83M
-18.21%-2.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-11.58%-2.67M
-60.08%-2.61M
-16.39%-2.47M
-13.63%-8.89M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-71.21%-7.83M
-18.21%-2.79M
Basic earnings per share
-5.26%-0.2
-53.85%-0.2
-11.76%-0.19
-13.11%-0.69
4.55%-0.21
-5.56%-0.19
-116.67%-0.13
-13.33%-0.17
-74.29%-0.61
-22.22%-0.22
Diluted earnings per share
-5.26%-0.2
-53.85%-0.2
-11.76%-0.19
-13.11%-0.69
4.55%-0.21
-5.56%-0.19
-116.67%-0.13
-13.33%-0.17
-74.29%-0.61
-22.22%-0.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 9.03%2.73M52.27%2.66M13.21%2.54M16.01%9.33M-2.03%2.84M5.03%2.5M126.02%1.75M12.66%2.24M74.87%8.04M21.77%2.89M
Selling and administrative expenses 26.76%437.01K-4.00%353.53K-17.06%342.69K4.13%1.63M15.23%503.05K-47.73%344.76K162.94%368.26K25.82%413.18K50.67%1.56M39.35%436.58K
-General and administrative expense 26.76%437.01K-4.00%353.53K-17.06%342.69K4.13%1.63M15.23%503.05K-47.73%344.76K162.94%368.26K25.82%413.18K50.67%1.56M39.35%436.58K
Research and development costs 6.20%2.29M67.29%2.31M20.06%2.19M18.89%7.7M-5.09%2.33M25.22%2.16M117.86%1.38M10.06%1.83M81.93%6.48M19.10%2.46M
Operating profit -9.03%-2.73M-52.27%-2.66M-13.21%-2.54M-16.01%-9.33M2.03%-2.84M-5.03%-2.5M-126.02%-1.75M-12.66%-2.24M-74.87%-8.04M-21.77%-2.89M
Net non-operating interest income expense -45.71%60.34K-54.19%54.72K-44.91%64.01K102.80%436.06K-14.28%89.29K73.55%111.14K338.62%119.45K493.51%116.18K685.68%215.02K531.30%104.17K
Non-operating interest income -45.71%60.34K-54.19%54.72K-44.91%64.01K102.80%436.06K-14.28%89.29K73.55%111.14K338.62%119.45K493.51%116.18K685.68%215.02K531.30%104.17K
Other net income (expense)
Income before tax -11.58%-2.67M-60.08%-2.61M-16.39%-2.47M-13.63%-8.89M1.57%-2.75M-3.14%-2.39M-118.26%-1.63M-7.88%-2.12M-71.21%-7.83M-18.21%-2.79M
Income tax
Net income -11.58%-2.67M-60.08%-2.61M-16.39%-2.47M-13.63%-8.89M1.57%-2.75M-3.14%-2.39M-118.26%-1.63M-7.88%-2.12M-71.21%-7.83M-18.21%-2.79M
Net income continuous Operations -11.58%-2.67M-60.08%-2.61M-16.39%-2.47M-13.63%-8.89M1.57%-2.75M-3.14%-2.39M-118.26%-1.63M-7.88%-2.12M-71.21%-7.83M-18.21%-2.79M
Minority interest income
Net income attributable to the parent company -11.58%-2.67M-60.08%-2.61M-16.39%-2.47M-13.63%-8.89M1.57%-2.75M-3.14%-2.39M-118.26%-1.63M-7.88%-2.12M-71.21%-7.83M-18.21%-2.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -11.58%-2.67M-60.08%-2.61M-16.39%-2.47M-13.63%-8.89M1.57%-2.75M-3.14%-2.39M-118.26%-1.63M-7.88%-2.12M-71.21%-7.83M-18.21%-2.79M
Basic earnings per share -5.26%-0.2-53.85%-0.2-11.76%-0.19-13.11%-0.694.55%-0.21-5.56%-0.19-116.67%-0.13-13.33%-0.17-74.29%-0.61-22.22%-0.22
Diluted earnings per share -5.26%-0.2-53.85%-0.2-11.76%-0.19-13.11%-0.694.55%-0.21-5.56%-0.19-116.67%-0.13-13.33%-0.17-74.29%-0.61-22.22%-0.22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
+17.56%
DexCom
DXCM
+5.92%
Hutchmed (China)
HCM
+4.39%
New Fortress Energy
NFE
+2.70%
Enerpac Tool
EPAC
+1.85%

Unlock the Full List